10 Worst Blue Chip Stocks to Buy
As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected to shift lower as and when the deals are made, supply chains adapt, and there is some...
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 14,481 | $9,184,285 | +232% | 0.61% |
| 2. | ARK Investment Management Catherine D. Wood | 13,694 | $8,685,055 | +4% | 0.09% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 6,623 | $4,200,505 | -82% | 0.04% |
| 4. | Bailard Inc Thomas Bailard | 4,034 | $2,558,484 | -70% | 0.07% |
| 5. | Impax Asset Management Ian Simm | 1,228 | $778,834 | -54% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | 23,880,537 | 2017-08-25 | Filing | ||
| $485.99 | 2,681 | 23,877,980 | 2017-08-25 | Filing | ||
| $485.28 | 5,723 | 23,875,299 | 2017-08-25 | Filing | ||
| $484.21 | 2,000 | 23,869,576 | 2017-08-25 | Filing | ||
| $482.87 | 4,485 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $844.61 | 1,000 | Officer | 12,931 | 2024-11-01 | Filing | |
| $1,059.28 | 2 | Director | 17,582 | 2024-10-01 | Filing | |
| $1,057.38 | 2 | Director | 17,584 | 2024-10-01 | Filing | |
| $1,056.68 | 3 | Director | 17,586 | 2024-10-01 | Filing | |
| $1,054.90 | 3 | Director | 17,589 | 2024-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,407,891 | $5,966,766,709 | 0.11% | |
| 2. | 8,925,880 | $5,661,061,035 | 0.12% | |
| 3. | 1,143,093 | $724,983,887 | 0.12% | |
| 4. | 710,335 | $450,515,767 | 0.08% | |
| 5. | 698,253 | $442,852,999 | 0.09% |
News See All
10 Jim Cramer Stocks with Huge Upside Potential
“I want to pull back the curtain and show you how a professional looks for stocks to buy and knows what to sell. There's no magic. There's no hidden talent.
11 Cheap ESG Stocks to Buy According to Hedge Funds
These days, it seems like everyone wants to wear the “saving the world” cape.
Billionaire Mario Gabelli's 10 Large-Cap Stock Picks with Huge Upside Potential
Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed by a research-driven equity investment style.
Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years
“This week we're celebrating the show's 20th anniversary, a little over a month late, but better late than never.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2025 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2025 Earnings Call Transcript April 29, 2025Regeneron Pharmaceuticals, Inc. misses on earnings expectations.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
11 Blue Chip Stocks to Invest in at 52-Week Lows
For the first time since 2023, the S&P 500 was seen in the market correction territory, according to US Bank (Wealth Management).
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
11 Best Extremely Profitable Stocks to Buy According to Analysts
While the S&P 500 is hovering near correction territory, marking five years since its COVID-19 drawdown. Wyne noted that the risks appear evenly distributed between bullish and bearish outlooks.
Billionaire Hedge Funds
